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The sarco-endoplasmic reticulum (SR/ER) plays an important role in the development and
progression of many heart diseases. However, many aspects of its structural organization
remain largely unknown, particularly in cells with a highly differentiated SR/ER network. Here,
we report a cardiac enriched, SR/ER membrane protein, REEP5 that is centrally involved in
regulating SR/ER organization and cellular stress responses in cardiac myocytes. In vitro
REEP5 depletion in mouse cardiac myocytes results in SR/ER membrane destabilization and
luminal vacuolization along with decreased myocyte contractility and disrupted Ca2+ cycling.
Further, in vivo CRISPR/Cas9-mediated REEP5 loss-of-function zebraﬁsh mutants show
sensitized cardiac dysfunction upon short-term verapamil treatment. Additionally, in vivo
adeno-associated viral (AAV9)-induced REEP5 depletion in the mouse demonstrates cardiac
dysfunction. These results demonstrate the critical role of REEP5 in SR/ER organization and
function as well as normal heart function and development.
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The sarco-endoplasmic reticulum (SR/ER) is a multifunctionalorganelle responsible for many essential cellular processesin eukaryotic cells, including protein translation, lipid
synthesis1, Ca2+ cycling2, protein trafﬁcking3, and organelle–
organelle communication4. The ER is a lipid-bilayer extension of
the outer nuclear membrane consisting of a continuous peripheral
ER network of tubules and interspersed sheets5. ER tubules are
generated mainly by stabilizing membrane curvature, and previous
studies have identiﬁed a few key evolutionary conserved protein
families involved in the formation of these tubular structures6.
However, many aspects of its structural organization and function
remain largely unknown, particularly in highly differentiated mus-
cle cells. Members of the reticulon and Yop1p/DP1/REEP protein
families contain a reticulon-homology domain (RHD) which is
essential for inducing and stabilizing high membrane curvature in
cross-sections of ER tubules7–9. In addition to membrane curvature
stabilization, ER tubules are also stabilized by forming a char-
acteristic polygonal network through membrane fusion mediated by
the atlastin family of dynamin-related GTPases10,11.
RHD proteins contain two closely-spaced hairpin integral
membrane structures (~35 amino acids in length), which have
been proposed to form arc-shaped oligomers, thus essential for
bending and stabilizing membrane curvature around the
tubules7,12. Of all RHD proteins, Yop1p from Saccharomyces
cerevisiae has been the most well-studied. Vertebrate homologs of
Yop1p are the family of receptor expression-enhancing proteins
(REEPs) and previous studies demonstrate their vital roles in
trafﬁcking the odorant receptor13 and G-protein coupled recep-
tors to the plasma membrane14. Despite the association of REEPs’
RHD domains to ER network formation, the precise role of
REEPs in ER formation, maintenance, and responses to ER stress
remains poorly understood. So far, six mammalian REEP
homologs have been identiﬁed, REEP1 and REEP2 are neuro-
enriched in mice15 and have been linked to hereditary spastic
paraplegia in patients and transgenic mice16,17. REEP3 and
REEP4 are required for mitotic spindle organization in pro-
liferative cells18. Mutations in REEP6 have been linked to human
retinopathies19,20. The role of REEP5, in comparison, remains
largely unknown.
Instabilities in ER structure and function lead to ER stress,
unfolded protein response, ER-associated degradation, and
autophagy21. In excitable muscle cells, their ER structures have
adapted to handle a large concentration of Ca2+, important
for regulated release of Ca2+ into the cytoplasm for muscle
contraction. This specialized smooth ER, termed the SR,
evolved to function in striated muscle22. However, differences
in protein expression and function between the ER and SR have
not been fully determined, resulting in poor characterization
and understanding of the formation and function of SR in
muscle22. The SR has been loosely divided into at least two
structural and functional domains termed the longitudinal SR
and the junctional SR23. Furthermore, different regions of the
SR have specialized to perform speciﬁc functions with respect
to the control of the excitation–contraction coupling24. It is
recognized in patients and animals that longitudinal and
junctional SR undergo signiﬁcant transformation following
heart failure25,26. While a great deal is known about SR struc-
ture and function in terms of cardiac muscle contraction,
considerably less is understood about how the SR is formed and
maintained.
Results
REEP5 is a conserved cardiac-enriched membrane protein. Our
previous proteomic experiments of mouse and human cardiac
myocytes, integrated with microarray tissue expression proﬁles
and phenotype ontology information identiﬁed poorly char-
acterized, evolutionary conserved, cardiac-enriched membrane
proteins27. Rank-ordered evaluation of these protein candidates
identiﬁed that REEP5 was one of these most highly ranked pro-
teins. Accordingly, we investigated the role of REEP5 in the
cardiac myocyte.
Given its identiﬁcation in both mouse and human myocyte
proteomic membrane isolations27, we ﬁrst performed a detailed
multispecies amino-acid sequence analysis of REEP5 which
showed 96% homology between human and mouse REEP5 and
73% between human and zebraﬁsh (Fig. 1a). Bioinformatics
analysis of extensive phylogeny further demonstrated signiﬁcant
clustering of mammalian REEP5 within the REEP family
(Supplementary Fig. 1a).
To verify human REEP5 membrane topology, we used the
multi-algorithm prediction tool TOPCONS (http://topcons.cbr.
su.se). All six prediction algorithms within this tool determined
that the N-terminus was cytosolic for human REEP5, with 2 or 4
predicted transmembrane helices (Fig. 1b). To conﬁrm these
predictions for human REEP5, we employed a membrane yeast
two-hybrid (MYTH) system, as previously described27,28 (Fig. 1c);
which takes advantage of the ability of ubiquitin fragments
(NubG and NubI) reconstitution, N-terminal TF transcription
factor tagged (TF-Cub) bait protein and ubiquitin fragments
tagged (NubI) prey protein were tested for protein–protein
interactions. To determine REEP5 membrane topology at the ER,
a noninteracting yeast ER integral membrane protein Ost1p was
fused at its C-terminus with NubI and NubG (mutated form)
which exposed its C-terminus to the cytosol. N-terminally tagged
TF-Cub-REEP5 interacted with Ost1p-NubI but not with Ost1p-
NubG, indicating that the N-terminus of REEP5 resides in the
cytosol (Fig. 1c). Thus, REEP5 consists of four hydrophobic,
hairpin transmembrane domains connected by a hydrophilic
segment with both the N- and C-termini facing the cytosol
(Fig. 1d). This membrane topology model is entirely consistent
with models of Yop1p and other REEP homologs6,29,30.
To assess cardiac enrichment of REEP5, we used publicly
available comprehensive tissue speciﬁc human RNASeq datasets
(Human Proteome Map) to determine REEP5 expression levels
across different tissues31. These data demonstrate broad REEP5
expression across several different tissues at both fetal and adult
stages, with an apparent increase in expression during develop-
ment. Importantly, of all the REEP family members, REEP5 was
signiﬁcantly enriched in the fetal and adult heart despite its broad
expression across many mouse tissues (Fig. 1e). Immunoblots of
diverse tissues in the adult mouse using solubilization buffer
containing 6M urea further demonstrated highest expression in
the ventricle (Fig. 1f). Abundant expression was also detected in
skeletal muscle (gastrocnemius) and kidney. Apparent REEP5
monomers (17 kDa) and trimers (51 kDa) were predominantly
expressed in the ventricle, while REEP5 dimers (34 kDa) were
seemingly the predominant form in the atria, suggesting
functional difference in REEP5 oligomerization status. Since
antibody speciﬁcity must always be evaluated carefully, anti-
REEP5 antibody speciﬁcity was conﬁrmed by blocking antibody
with 10 μg of a bacterially expressed, puriﬁed 6xHis-tagged
REEP5 (Fig. 1g).
We next queried publicly available GEO RNA-seq datasets
containing data for human and mouse cardiovascular diseases to
determine changes in REEP5 expression. As shown in Fig. 1h,
REEP5 levels changed dramatically with several cardiac diseases.
A marked decrease in REEP5 mRNA levels was seen in severe
dilated cardiomyopathy (DCM) in the mouse and in one human
dataset, albeit not signiﬁcantly. Myocardial infarction (MI) in the
mouse and ischemic cardiomyopathy in the human showed a
downregulation of REEP5. Similarly, pressure overload-induced
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-14143-9
2 NATURE COMMUNICATIONS |          (2020) 11:965 | https://doi.org/10.1038/s41467-019-14143-9 | www.nature.com/naturecommunications
heart failure via transverse aortic constriction (TAC) led to a
downregulation of REEP5 at 2 and 10 days post surgery; however,
a moderate increase was seen after 21 days. By contrast,
inﬂammatory DCM in humans showed an upregulation of
REEP5 RNA levels whereas rejected cardiac allografts in human
showed the greatest decrease in REEP5 levels. These results
showed that REEP5 levels appear to be dynamic under certain
cardiac conditions and suggest a potential role of REEP5 in the
progression of heart diseases, although the speciﬁc mechanisms
and directions of changes are not well deﬁned.
Next, we performed immunoblots using mouse cardiac tissue
from a phospholamban (PLN) R9C DCM model32, 4-week post
TAC heart failure model33, and 2-week post LAD ligation MI
model34. A marked increase in REEP5 levels was seen in the 4-
week TAC mouse hearts whereas REEP5 protein levels were
decreased in the LAD ligation MI model (Fig. 1i). Brain
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natriuretic peptide (BNP), a robust biomarker for heart failure,
dramatically increased in the MI model. PLN R9C mutant DCM
mice hearts showed decreased REEP5 levels. BNP levels were very
slightly increased in the R9C hearts. Immunoblotting analysis was
also carried out in human cardiac samples of idiopathic and
ischemic cardiomyopathy. In idiopathic cardiomyopathy, REEP5
and myosin heavy chain β (MF20) levels were elevated. In
contrast, REEP5 was downregulated in ischemic cardiomyopathy;
in agreement with the GEO data (Fig. 1j).
REEP5 localizes to the myocyte SR and j-SR membrane. We
next performed IF analysis of endogenous REEP5 in cultured
mouse neonatal cardiac myocytes (CMNCs) (Fig. 2a) and acutely
dissociated primary adult mouse cardiac myocytes (Fig. 2b, c). As
shown in Fig. 2a, REEP5 demonstrated a consistent SR/ER stri-
ated staining pattern in CMNCs, with sarcomeric doublet REEP5
patterns observed ﬂanking the z-disks highlighted by F-actin
staining, suggesting its localization to the junctional-SR. IF co-
staining between REEP5 and SERCA2, a known cardiac SR
protein, demonstrated a very high degree of co-localization
between the two proteins (Fig. 2b). Further orthogonal and three-
dimensional reconstructive analyses conﬁrmed strong co-
localization with SERCA2 (Pearson co-localization coefﬁcient of
0.59 ± 0.02; data presented as mean ± SEM) in isolated adult
ventricular cardiac myocytes (Fig. 2c), indicating REEP5 locali-
zation to the SR in cardiac myocytes. In adult mouse ventricular
cardiac myocytes, three-dimensional reconstructive analysis
demonstrated a Pearson’s co-localization coefﬁcient of 0.64 ± 0.04
between REEP5 and α-actinin, indicating a strong co-localization
(Supplementary Fig. 2a, b). Further statistical analysis revealed an
average of 99.8 ± 0.1% of α-actinin co-localized with REEP5 while
58.4 ± 1.0% of REEP5 co-localized with α-actinin, suggesting
REEP5 localization to the j-SR, but also in patterns indicative of
longitudinal SR. Additional analyses revealed strong co-
localization between REEP5 and Ryanodine Receptor 2 (RyR2)
(Pearson coefﬁcient of 0.76 ± 0.04), and between REEP5 and
triadin, with a Pearson coefﬁcient of 0.68 ± 0.12 (Supplementary
Fig. 2c, d). These results validate REEP5’s localization to the j-SR
membrane that is closely tethered to the cell membrane and
contractile machinery in adult striated muscles.
In vitro REEP5 depletion results in SR dysfunction. To char-
acterize the function of REEP5 in vitro, CMNCs were transduced
with a lentiviral REEP5-shRNA construct. Temporal analysis of
REEP5 protein levels by immunoblot showed ~60% knockdown
was achieved 48 h post transduction with knockdown of 70%
following 96 h (Fig. 3a, b). Confocal imaging of transduced cells
revealed pronounced vacuolization and disorganization of the SR/
ER visualized with ER-Tracker (Fig. 3c). Quantitatively, vacuoli-
zation of the SR/ER was observed as soon as 24 h post trans-
duction and observed in nearly all cells at 96 h. To conﬁrm that
the observed vacuolization was not a result simply of dying cells
and cell death, we treated cultures with the caspase inhibitor,
100 µM z-vad-fmk, as described previously35. Under these
conditions, luminal vacuoles were still observed in REEP5
shRNA-infected CMNCs in the presence of z-vad-fmk, ruling out
that these morphological changes are simply a result of cell death
(Supplementary Fig. 3a), rather they appear upstream of any
activated caspase activities.
ER stress plays important roles in contributing to cardiac
diseases36. To determine if REEP5 depletion-induced structural
abnormalities were related to functional impairment, we ﬁrst
assayed for ER stress activity and cell viability. CMNCs were
transduced with REEP5-shRNA and intracellular oxidative stress
was measured via staining for reactive oxygen species (ROS),
reﬂective of ER stress (Fig. 3d). CellRox ﬂuorescence demon-
strated a twofold increase in ROS levels with REEP5 depletion
(Fig. 3d). Tunicamycin (5 µg/ml) was used as a cell stress inducer,
which increased ROS levels further compared to wild-type
CMNCs treated with tunicamycin. Further analysis of ER stress
markers, GRp78, GPp94, and ATF4 indicated increased ER stress
with REEP5 depletion with/without tunicamycin (Fig. 3f). To
assess cell viability, MTT assays were conducted to measure cell
metabolic state upon REEP5 depletion and demonstrated a
signiﬁcant decrease in cell viability in cardiac myocytes upon
REEP5 depletion (Fig. 3e). Similarly, increased cleaved caspase-12
levels upon REEP5 depletion were observed, indicating activation
of ER-dependent apoptosis37 (Fig. 3f). In addition, we performed
mitochondrial membrane potential (MMP) measurements in
cardiac myocytes and showed that REEP5 depletion resulted in
signiﬁcant dissipation of the mitochondrial inner membrane
electrochemical potential, indicating impaired cellular health and
function in the cardiac myocyte (Fig. 3g).
REEP5 depletion leads to compromised myocyte contractility.
IF of virally mediated REEP5 depletion in adult cardiac myocytes
revealed prominent SR vacuoles as shown by REEP5 and RyR2
immunostaining (Fig. 4a). Three-dimensional reconstruction of
the SR marked by RyR2 staining further demonstrated the
vacuolated SR in REEP5 depleted myocytes as opposed to the
striated, interconnected SR network in the control myocytes
(Fig. 4b). Transmission electron microscopy (TEM) analysis
revealed that REEP5 depleted adult cardiac myocytes showed
signiﬁcant disruption of SR integrity, with deformed SR mem-
branes and apparent vacuoles, along with deformed cardiac t-
tubules, compared to control cells (Fig. 4c). Next, we performed
optical imaging edge analysis of REEP5 depleted adult cardiac
myocytes to measure myocyte contractility of spontaneously
contracting cells (Fig. 4d). REEP5 depleted myocytes demon-
strated a signiﬁcant impairment in fractional shortening of the
myocytes (0.3 ± 0.1% compared to 12.4 ± 1.2% fractional short-
ening per contractile event in the control myocytes; data
Fig. 1 REEP5 is an evolutionarily conserved, muscle-enriched membrane protein. a A multispecies alignment of REEP5 from vertebrates. b Prediction of
human REEP5 protein topography generated by TOPCONS. cMembrane yeast two-hybrid assay of REEP5 membrane topology. SD-WL is yeast media that
lacks tryptophan and leucine and selects for cells that contain both bait and prey plasmids. SD-WLAH +10 nM 3-AT is yeast media that lacks tryptophan,
leucine, adenine, and histidine and selects for cells in which bait and prey are interacting. d Predicted membrane topology model of human REEP5
generated by modiﬁcation of a T(E)Xtopo output in Protter (http://wlab.ethz.ch/protter). e REEP5 mRNA transcript levels obtained from Human Protein
Atlas across various mouse tissues. f Immunoblot of REEP5 protein expression in mouse tissues. Asterisks to the right indicate the number of predicted
REEP5 oligomers detected based on anticipated molecular weight. g Immunodepletion of REEP5 antigens with bacterially expressed 6xHis-REEP5. h GEO
RNA-seq datasets demonstrate changes in REEP5 expression across various mouse and human cardiovascular diseases; * indicates a statistically signiﬁcant
p < 0.05 in a Tukey’s multiple comparison analysis. Data are presented as mean ± SEM with n= 3 biologically independent measurements. i Immunoblot
analysis of REEP5 and BNP expression from cardiac tissue of hypertrophic cardiomyopathy (HCM), myocardial infarction (MI), and dilated cardiomyopathy
(DCM) mouse models. j Immunoblot analysis of REEP5, BNP, and MHC expression from human cardiac samples of normal, idiopathic, and ischemic
cardiomyopathy. Source data containing original uncropped immunoblots are provided as a Source Data ﬁle.
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Fig. 2 REEP5 expression shows consistent SR staining pattern in cardiac myocytes. a Immunoﬂuorescence analysis of endogenous REEP5 expression
(green) and phalloidin-rhodamine staining (red) in CMNCs. Right panel, line-scan analysis (from yellow line) demonstrates SR expression pattern in
CMNCs. Scale, 10 μm. b Immunoﬂuorescence of isolated adult mouse cardiac myocytes with REEP5 (blue) co-stained with SERCA2 (green) and phalloidin-
rhodamine (red). Scale, 20 μm (left panel), 10 μm (right panel). c Orthogonal projection, three-dimensional reconstructive and line-scan analyses
demonstrates co-localization between REEP5, SERCA2, and phalloidin signal. (Left panel): the top panels represent cell imaging in the x–z plane, while side
panels represent cell imaging in the y–z plane. All images shown are representative of approximately 40–50 total images captured per condition, n= 3
independent biological replicates.
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presented as mean ± SEM), suggesting severe functional impair-
ment of myocyte contractility (Fig. 4d, right) with a signiﬁcant
reduction in the recorded events (0.27 ± 0.07 Hz in scram com-
pared to average null values (below detectable threshold) in
REEP5 KD; p= 0.0194). In addition, Ca2+ sensor Fura2-AM
measurements were performed to characterize Ca2+ cycling in
REEP5 depleted myocytes (Fig. 4e). A signiﬁcant decrease in the
number of spontaneous Ca2+ transients (1.07 ± 0.05% in scram
vs. 0.47 ± 0.03% in REEP5 KD; p= 0.0006) and an increased peak
amplitude (25 ± 1.5% in scram controls vs. 58.6 ± 1.8% in REEP5
KD; p= 0.0002) of these transients were observed in REEP5
depleted myocytes (Fig. 4e, right).
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The C-terminal domain of REEP5 contributes to SR integrity.
To study the biochemical properties of REEP5, we created two
tagged REEP5 constructs (Fig. 5a). REEP5 was fused to a V5 tag
followed by 6xHis tag for afﬁnity puriﬁcations using Ni-NTA
beads; alternatively, CnVA-tagged38 (StrepII-6xHis, 3xFlag)
REEP5 was generated and used. Immunoblot analysis showed
robust expression of both constructs in HEK293 cells (Fig. 5b, d).
Interestingly, addition of increasing dithiothreitol (DTT) con-
centrations led to dose-dependent decrease of observed REEP5
dimers (Fig. 5c), suggesting disulﬁde bridge(s) may be required
for this dimerization. Moreover, overexpression of recombinant
proteins CnVA-REEP5 and REEP5-V5-6xHis followed by
immunoprecipitation using anti-V5 antibody identiﬁed CnVA-
REEP5 in the elution, indicating homodimerization of REEP5
molecules (Fig. 5d). Our results are consistent with previous yeast
experiments that showed the formation of DP1/Yop1p immobile
oligomers39. This, however, does not rule out the presence of
heterodimers of REEP5 with other proteins, or other REEP iso-
forms. Furthermore, expression of a ﬂuorescently tagged dimer-
ized REEP5 construct (REEP5-REEP5-EYFP) in C2C12 myoblasts
marked the ER network more robustly, suggesting functionality of
REEP5 dimers (Supplementary Fig. 4a).
The N- and C-termini cytosolic domains represent the major
differences between REEP1-4 and REEP5-6 subfamilies30. To
determine the importance of various domains in REEP5 to its
function, we constructed various EYFP tagged REEP5 truncated
mutants (Fig. 5g). Immunoblotting revealed that stable, sodium
dodecyl sulfate (SDS)-resistant dimers were detected in C2C12
myoblasts expressed with REEP5-EYFP, REEP5X2-EYFP, and
Δ1–36 REEP5-EYFP (Fig. 5e). Interestingly, loss of REEP5 dimers
was observed in cells expressing Δ114–189 REEP5-EYFP and
Δ1–36/114–189 REEP5-EYFP, suggesting that the cytosolic
carboxyl terminal domain is required for the formation of stable
dimers. Expression of the carboxyl-terminal truncated mutant of
REEP5 (Δ114–189 REEP5-EYFP) in C2C12 myoblasts led to a
vacuolated ER network as observed with REEP5 depletion in
cardiac myocytes (Figs. 3c and 4a). To conﬁrm the origins of the
vacuoles, recombinant mCherry fusion proteins with mitochon-
dria targeting peptide (mCherry-mito) or with a ER lumen
retention peptide (mCherry-KDEL) were co-expressed with
Δ114–189 REEP5-EYFP in C2C12 myoblasts (Fig. 5h). Co-
expression of mCherry-KDEL, as an ER–luminal protein,
occupied the entire vacuoles generated by expression of
Δ114–189 REEP5-EYFP, indicating that the observed vacuoles
originate from the ER membrane. Consistent with this hypoth-
esis, expression of Δ1–36 REEP5-EYFP did not affect the
morphology of the ER and co-localized strongly with mCherry-
KDEL, Δ114–189 REEP5-EYFP and Δ1–36/114–189 REEP5-
EYFP signiﬁcantly disrupted the peripheral ER morphology and
caused prominent luminal swelling and vacuolization (Fig. 5i). To
test whether disruption of the ER network affects microtubule
dynamics, we co-expressed Δ114–189 REEP5-EYFP and
mCherry-α-Tubulin in C2C12 myoblasts and showed intact
microtubule organization in Δ114–189 REEP5-EYFP transfected
cells, suggesting the SR/ER shaping role of REEP5 is independent
of microtubule polymerization (Supplementary Fig. 4b).
REEP5 interacts with known SR/ER shaping proteins. Mass
spectrometry-based studies identiﬁed REEP5-associated proteins
as nickel-His puriﬁcation of CnVA-REEP5 in HEK293 (Fig. 6a)
resulted in the identiﬁcation of several members of the reticulon
(RTN) and atlastin (ATL) families of proteins with a marked
increased fold-change enrichment in puriﬁed REEP5-associated
membrane complexes (Fig. 6b). Assessment of ACTC1, MYL6,
and GAPDH as negative controls in both conditions demon-
strated similar average peptide intensity with minimal fold-
change difference detected. Notably, we identiﬁed RTN4 (Nogo-
A/B), RTN3, and ATL2 solely in the REEP5 transfected cells,
while ATL3 and CKAP4, were detected under non-transfected
and transfected conditions, although at a 15-fold and 5-fold
enrichment in the REEP5 transfected cells were detected,
respectively.
To identify which RTN, ATL, and CKAP isoforms are highly
expressed in cardiac myocytes, we again analyzed publicly
available transcriptomic datasets from the Human Proteome
Map31 for RTN, ATL, and CKAP families of proteins. Of
particular interest, Nogo-A/B/RTN4, ATL3, and CKAP4/Climp-
63 were signiﬁcantly enriched in the fetal and adult heart, similar
to REEP5 (Fig. 6c).
Previous experiments demonstrated the interaction between
RTN1 and DP1/Yop1p in yeast and showed subsequent
oligomer formation was essential for tubular ER localization
and ER tubule formation39. Moreover, immunoblots of the
REEP5 nickel-His puriﬁcation eluate conﬁrmed the presence of
RTN4, ATL3, and CKAP4 (Fig. 6d). Here, we overexpressed
CnVA-REEP5 and Myc-RTN4 (Nogo-B) plasmids in HEK
cells (Fig. 6e), followed by co-immunoprecipitation with anti-
REEP5 (Fig. 6f, left) or anti-Nogo-A/B antibodies (Fig. 6f, right).
In both experiments, Nogo isoforms were coprecipitated
with REEP5 conﬁrming the physical interaction between these
two proteins, at least in an overexpression system (Fig. 6f). Next,
co-immunoprecipitations using mouse ventricular membrane
fractions (microsome) were performed. Immunoprecipitating
Fig. 3 In vitro REEP5 depletion in cardiac myocytes results in SR/ER membrane destabilization and dysfunction. a Immunoblotting analysis of lentiviral-
mediated REEP5 depletion in CMNCs at 0, 24, 48, 72, 96 h post transduction. b Quantitative analysis of REEP5 expression levels showed 60% reduction
48 h after REEP5 shRNA transduction. Quantiﬁcation was done under ×40 objective lens and approximately 40–50 cells were scored for each experimental
condition, n= 3 independent biological replicates; data are presented as mean ± SEM. c Confocal imaging of CMNCs stained with ER-tracker showed SR/
ER vacuoles (yellow arrows) 48 h post viral transduction. Vacuoles were observed starting 24 h post transduction, peaking after 96 h post lentiviral
infection with REEP5 shRNA. Quantiﬁcation was done under ×40 objective lens and approximately 30–40 cells were scored for each experimental
condition, n= 3 independent biological replicates; data are presented as mean ± SEM. d Confocal imaging of CMNCs stained with CellROX oxidative stress
dye 48 h post viral transduction with REEP5 shRNA. Scale, 10 μm. Spectrophotometric analysis showed a marked increase in ROS levels following shRNA-
mediated REEP5 depletion in the presence and absence of tunicamycin, n= 40–50 cells examined under ×40 objective, n= 3 independent biological
replicates; data are presented as mean ± SEM. e Cardiac myocyte cell viability levels 48 h post viral transduction with REEP5 shRNA measured by MTT
assay, n= 3 independent biological replicates; data are presented as mean ± SEM. f Immunoblotting analysis of REEP5, ER stress markers (GRp78, GRp94,
and ATF4), and ER-dependent apoptosis marker (caspase 12) expression levels upon REEP5 depletion in the presence or absence of tunicamycin.
g Confocal imaging of CMNCs stained with mitochondrial membrane potential dye JC-1 48 h post viral transduction with REEP5 shRNA. Scale, 10 μm, n=
40–50 cells examined under ×40 objective lens over 3 independent experiments. Asterisks indicate a statistically signiﬁcant p value in a Tukey’s multiple
comparison analysis where *p < 0.05, **p < 0.01, and ***p < 0.001; data are presented as mean ± SEM. Source data containing original uncropped
immunoblots are provided as a Source Data ﬁle. All images shown are representative of approximately 30–40 total images captured per condition.
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REEP5, followed by immunoblots, showed REEP5 co-
precipitated Nogo-A, Nogo-B, ATL3, an ATL3 apparent dimer,
and CKAP4 in these lysates (Fig. 6g). REEP5 in a dimer, and
oligomer state were detected (Fig. 6g, lower panel). Co-
immunoprecipitations in a reverse strategy were also performed
(Fig. 6h–j). In these studies, we showed that all four antibodies
were able to coprecipitate REEP5, mostly as higher molecular
weight dimer and oligomer, along with their respective antigens.
Finally, as parallel experiments, co-immunoprecipitation assays
performed using total neonatal ventricular cardiac lysate also
revealed similar REEP5 interactions with Nogo-A/B, ATL3, and
CKAP4 (Supplementary Fig. 5a).
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In vivo phenotype analysis of REEP5 depletion in zebraﬁsh.
We next used the zebraﬁsh embryonic model, with its rapid ex
utero development, to investigate the role of REEP5 in vivo. We
performed IF analysis at 48 and 96 h post fertilization (hpf) to
examine the localization of REEP5 expression within cardiac
myocytes. Co-staining with zn-8 (localized to the membrane) and
DAPI revealed REEP5 expression within both ventricular and
atrial cardiac myocytes, with minimal nuclear or membrane
localization evident (Fig. 7a).
To determine the function of REEP5 during zebraﬁsh heart
development, embryos were injected with a titrated minimum
functional dosage of 1 ng of REEP5 morpholino (MO) at the one-
cell stage to block REEP5 translation. Reduced REEP5 expression
was observed in MO embryos (Supplementary Fig. 6a). Using Tg
(myl7:EGFP) embryos, demarcating differentiated cardiac myo-
cytes, REEP5 morphant embryos demonstrated abnormalities in
heart morphology with a lack of looping at 48 hpf (Supplemen-
tary Fig. 6b, c). To determine the speciﬁcity of the REEP5 MO
sequence, REEP6 (92% homology to REEP5) MO sequence was
used as a control. Investigations into REEP6 MO embryos
revealed no observable cardiac phenotype, supporting the
speciﬁcity of REEP5 MO associated phenotypes (Supplementary
Fig. 6d). Optical imaging and IF of the REEP5 morphants showed
defects in cardiac looping where a linear-oriented 2-chambered
heart morphology in REEP5, compared to a fully looped heart in
the sham controls (Supplementary Fig. 6e–h). These morpholo-
gical defects were accompanied by irregularities in heart rhythm
suggestive of an atrioventricular heart block. Further optical
imaging analysis of cardiac conduction patterns demonstrated
arrhythmogenic beating rhythms with asynchronous and skipped
heart beats in REEP5 MO embryos compared to controls
(Supplementary Fig. 6i and Supplementary Movies 1–3). The
regular heartbeat of a control embryo by 96 hpf is a 1:1 ratio of
atrial:ventricular contractions. Upon loss of REEP5 function, this
ratio became offset with the atrium beating 3× to every
ventricular contraction. TEM analysis of control embryos
revealed cardiac myocytes with organized sarcomeres displaying
well-ordered actin–myosin ﬁlaments and intact SR membranes
(Supplementary Fig. 6j, k). However, TEM analysis of REEP5
morphants revealed apparent SR membrane vacuolization in
zebraﬁsh ventricular tissue along with structural discontinuity
between sarcomeres (Supplementary Fig. 6l, m).
In vivo functional rescue experiments by injecting wild-type
REEP5 mRNA in REEP5 MO zebraﬁsh embryos showed co-
injection efﬁciently rescued the cardiac dysfunction phenotypes
observed in REEP5 MO embryos, resulting in signiﬁcantly
improved heart rate (140 ± 11 bpm in control vs. 56 ± 4 bpm in
REEP5 MO vs. 134 ± 4 bpm in REEP5 MO+ REEP5 mRNA
injected embryos; p= 0.004. Data presented as mean ± SEM and
heart morphology in the rescued morphants (Supplementary
Fig. 6n–p). Further analysis showed reduced AV dys-synchrony
phenotype with an apparent healthy ratio of 1:1 atrial:ventricular
contractions in the rescued embryos (0.3 ± 0.3% in control vs.
83 ± 4% in REEP5 MO vs. 10 ± 2% in REEP5 MO+ REEP5
mRNA injected embryos; p < 0.0001). Immunoblots of REEP5-
interacting proteins identiﬁed in Fig. 6 were also performed and
showed a marked increase in the protein expression levels of
ATL3 (0.48 ± 0.23 in control vs. 0.89 ± 0.19 in REEP5 MO
embryos; densitometric ratio normalized to GAPDH, p= 0.04)
(Supplementary Fig. 6q).
To address potential off-target effects of the REEP5 MO
mutant and to validate the REEP5 MO model, we used CRISPR/
Cas9 to generate a REEP5 loss-of-function mutant in zebraﬁsh40.
High resolution melt (HRM) analysis of REEP5-targeted gRNA
and Cas9 mRNA injected zebraﬁsh embryos (F0) showed a
marked temperature shift in the melt curves comparing controls
and REEP5 gRNA injected embryos, conﬁrming the cutting
efﬁciency of REEP5-targeted gRNA (Supplementary Fig. 7a).
Depletion of REEP5 protein expression was conﬁrmed by
subsequent immunoblotting and IF analyses of mutant hearts
(Supplementary Fig. 7b, c). To determine the functional and
cutting speciﬁcity of our designed gRNA, we performed dose
response gRNA injection conditions (1×, 2×, 3×) (Fig. 7b–e). We
determined 2× gRNA provided high phenotypic penetrance and
low toxicity and these injected embryos were used for all
subsequent functional analysis. Optical imaging of cardiac
morphology and contraction in REEP5 gRNA injected ﬁsh
showed cardiac developmental defects, displayed as a lack of
cardiac looping, as well as atrio-ventricular conduction defects
with dysynchronous beating rhythms (Fig. 7f–h). Further
quantiﬁcation showed that more than 40% of the 2× and 3×
gRNA injected F0 embryos showed cardiac developmental defects
with a linearized heart (Fig. 7i). In all experimental conditions
there was reduced heart rate and increased atrio-ventricular dys-
synchrony associated with REEP5 gRNA injection. Increasing
gRNA concentration led to a greater number of embryos
displaying more severe developmental defects with reduced heart
rate and impaired trunk circulation (Fig. 7j, k and Supplementary
Movies 4–8). These defects were associated with poor survival
since 60% of all analyzed REEP5 morphant and crispant mutants
embryos did not survive past 7 days, highlighting the importance
of REEP5 during embryonic heart development.
Next, we generated germline reep5 CRISPR homozygous
maternal zygotic (MZ) zebraﬁsh mutants. Our sequencing
analysis showed successful editing of the reep5 gene at the
gRNA target site, resulting in the generation of reep5
homozygous CRISPR mutants (Fig. 8a). However, analysis of
F4 reep5 germline CRISPR MZ mutant embryos showed
minimal morphological abnormalities nor developmental
defects and did not present with the complete lethality we
had observed previously (Fig. 8b–e and Supplementary
Movie 9).
Short-term treatment with verapamil, a voltage-gated Ca2+
channel blocker, has been proposed as a rapid heart failure
Fig. 4 In vitro REEP5 depletion leads to SR vacuolization and sarcomeric dysfunction in adult mouse cardiac myocytes. a Immunoﬂuorescence of adult
mouse cardiac myocytes stained with REEP5 and RyR2 48 h post viral transduction with REEP5 shRNA. Scale, 20 μm. b Three-dimensional reconstruction
analysis of RyR2 staining of the SR in Scram and REEP5-depleted myocytes. c Transmission electron microscopy in REEP5-depleted adult mouse cardiac
myocytes revealed SR vacuoles and disrupted SR membranes compared to scram controls. M mitochondria, SR sarcoplasmic reticulum, TT T-tubule, V
vacuoles. Scale, 0.5 nm. d Optical measurements of spontaneous myocyte contractility in scram and REEP5-depleted adult mouse cardiac myocytes
revealed a signiﬁcant decrease in both fractional shortening measurements and frequency in REEP5-depleted myocytes. Left: still images of representative
cardiac myocytes. Scale, 20 μm. Red line indicates region of image used to generate kymographs shown above contractile pulses tracings. n= 30 cells
examined over three independent experiments; data are presented as mean ± SEM. e Ca2+ imaging of myocytes showing the frequency of Ca2+ waves and
Ca2+ transients amplitude 48 h post viral transduction with REEP5 shRNA, n= 40–50 cells examined per condition over 3 independent experiments.
Asterisks indicate a statistically signiﬁcant p value in a Tukey’s multiple comparison analysis where *p < 0.05 and ***p < 0.001; data are presented as
mean ± SEM. All images shown are representative of approximately 30–40 total images captured per condition.
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model41. Zebraﬁsh at 48 hpf were treated with 0.6 mg/mL
verapamil for 30 min to induce a rapid decrease in heart
rate and contractility, ultimately leading to heart failure41. The
reep5 germline mutants treated with verapamil displayed
sensitized cardiac dysfunctional phenotypes highlighted by a
marked reduction in heart rate compared to control embryos
(133 ± 5 bpm in control vs. 125 ± 4 bpm in reep5 CRISPR ﬁsh
under resting conditions, compared to 131 ± 4 bpm in control vs.
99 ± 4 bpm in the reep5 CRISPR ﬁsh with verapamil treatment;
p= 0.003. Data presented as mean ± SEM (Fig. 8f). Compensa-
tory network induced by deleterious mutations in CRIPSR
germline mutants, but not in zebraﬁsh knockdown models such
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as morphants or crispants, has been described previously42. Thus,
we next examined the possibility of such genetic compensation by
injecting REEP5 MO into reep5 germline mutants and showed
that reep5 mutants injected with REEP5 MO were phenotypically
normal compared to overt cardiac abnormalities in the REEP5
morphants (Fig. 8g–j and Supplementary Movie 10). Further
quantiﬁcation showed reep5 CRISPR mutants were less sensitive
to MO injection, with ~2 ± 1% of reep5 CRISPR mutants vs 65 ±
4% of REEP5 MO embryos showed cardiac developmental defects
with a linearized heart (Fig. 8k). Lastly, immunoblots of the
REEP5 interacting proteins showed a marked increase in the
protein expression levels of RTN4 (0.89 ± 0.16 in control vs.
1.99 ± 0.18 in reep5 CRISPR ﬁsh; densitometric ratio normalized
to α-actin, p= 0.01), suggesting potential compensatory mechan-
ism regulated by RTN4 upregulation in response to the loss of
REEP5 in zebraﬁsh (Fig. 8l).
In vivo AAV9-mediated REEP5 depletion in mice. In parallel to
REEP5 depletion in zebraﬁsh embryos, we performed intraper-
itoneal injections of AAV9 virus carrying scrambled shRNA or
REEP5 shRNA in neonatal mice (P10). Immunoblotting analysis
of REEP5 4 weeks post viral infection showed near depleted levels
of REEP5 in the AAV9 REEP5 shRNA injected mouse hearts
(Fig. 9a). All AAV9 REEP5 shRNA injected mice developed lethal
cardiac dysfunction at 4 weeks post viral transduction and we
never observed animals surviving past 5 weeks post injection,
compared to healthy AAV9 scram injected littermates.
Hematoxylin and eosin (H&E) and Masson’s trichrome
staining of the REEP5 depleted myocardium showed general
disorganization of the myocardium compared to scram controls
(Fig. 9b). Masson’s trichrome staining revealed greater ﬁbrotic
regions, with signiﬁcant collagen deposition in the REEP5
depleted ventricular myocardium (Fig. 9b, bottom panels). TEM
analysis (Fig. 9c) of control ventricular tissue showed organized
sarcomeres displaying well-ordered actin–myosin ﬁlaments,
whereas REEP5 depleted ventricular myocardium showed
disordered sarcomere organization and SR membrane vacuoliza-
tion, consistent with the observations in REEP5 depleted adult
cardiac myocytes and zebraﬁsh embryos (Fig. 9c). Echocardio-
graphic assessment of cardiac function of AAV9 scram shRNA
and REEP5 shRNA injected mice was performed (Fig. 9d) and
echocardiographic B-mode and M-mode measurements revealed
signiﬁcant myocardial dilatation and cardiac contractile dysfunc-
tion (Fig. 9e), with a marked decrease in cardiac ejection fraction
61.0 ± 0.9% in scram vs. 23.1 ± 2.2% in REEP5 KD; p < 0.0001,
stroke volume (46 ± 2 µL in scram compared to 18 ± 2 µL in
REEP5 KD; p < 0.0001), and cardiac output (19.0 ± 0.5 mL/min in
scram vs. 10.1 ± 1.2 mL/min in REEP5 KD; p= 0.0002) in AAV9
REEP5 shRNA injected mice compared to its AAV9 scram
injected littermates (Fig. 9e).
REEP5-depleted myocardium had elevated expression levels of
ER stress markers GRp78 (1.5 ± 0.2 in scram vs. 2.5 ± 0.5 in
REEP5 KD; densitometric ratio normalized to α-actin, p= 0.13.
Data presented as mean ± SEM, GRp94 (0.05 ± 0.01 in scram vs.
1.06 ± 0.84 in REEP5 KD; p= 0.27), XBP1 (0.07 ± 0.01 in scram
vs. 0.13 ± 0.02 in REEP5 KD; p < 0.05), ATF4 (0.04 ± 0.01 in
scram vs 0.79 ± 0.11 in REEP5 KD; p= 0.002), and CHOP
(0.02 ± 0.01 in scram vs. 0.17 ± 0.05 in REEP5 KD; p= 0.001)
(Fig. 9f). In line with our previous in vitro studies in cardiac
myocytes (Fig. 3f), a marked increase in the expression levels of
cleaved caspase 12 (0.03 ± 0.01 in scram vs. 0.25 ± 0.06 in REEP5
KD; p= 0.004) was observed, indicating activated ER stress-
induced apoptotic activity in the REEP5 depleted ventricular
myocardium (Fig. 9f).
Lastly, we measured expression levels of the newly identiﬁed
REEP5 interacting proteins. Immunoblots revealed signiﬁcantly
increased levels of RTN4 (1.1 ± 0.2 in scram vs. 2.3 ± 0.5 in
REEP5 KD; densitometric ratio normalized to α-actin, p= 0.01),
ATL3 (0.14 ± 0.04 in scram vs. 0.45 ± 0.07 in REEP5 KD; p=
0.02), and CKAP4 (0.59 ± 0.04 in scram vs. 1.52 ± 0.31 in REEP5
KD; p= 0.04) in REEP5 depleted hearts (Fig. 9g). Interestingly,
we also investigated protein levels of these SR/ER shaping
proteins in the context of cardiac pressure overload-induced
hypertrophy and heart failure and were able to demonstrate
consistent and signiﬁcant elevations in protein levels of REEP5,
RTN4, ATL3, and CKAP4 in failing mouse hearts following aortic
constriction (see Supplementary Fig. 8a).
Discussion
This study details a fundamental role of REEP5 in the cardiac
myocyte, demonstrates that this protein is essential for SR/ER
organization and proper function, identify its protein interac-
tions, and shows that its deletion can result in cardiac functional
and developmental defects. REEP5 expression was demonstrated
to be particularly muscle-speciﬁc with the highest protein
expression in the mouse ventricles and skeletal muscle. Our
results show that REEP5 expression is detected across the SR
network in cardiac myocytes, co-localizing with known SR mar-
kers (SERCA2, α-actinin, RyR2, and triadin), thereby regulating
SR function in cardiac muscle.
Previous experiments in yeast have established the interactions
between REEP1, RTN1, and ATL1 coordinate the generation and
maintenance of the tubular ER network30. In both mouse neo-
natal cardiac myocytes and adult cardiac microsomes, we
demonstrated physical interactions between REEP5 and other SR/
ER structure proteins including RTN4/Nogo-A/B, ATL3, and
Fig. 5 The C-terminal cytosolic domain of REEP5 is required for stabilizing SR/ER morphology. a Schematic diagrams of REEP5 constructs used for
REEP5 dimerization study shown in Fig. 5b–d. b Immunoblot analysis of endogenous REEP5 monomer (~17 kDa) and REEP5 dimer (~34 kDa), and
exogenous REEP5 monomer (~22 kDa) and exogenous REEP5 dimer (~44 kDa) in HEK293 transfected with REEP5-V5-6xHis construct. c Immunoblots of
REEP5 dimer dissociation in response to increasing DTT concentration. Diamonds to the left indicate the detection of endogenous (orange) and exogenous
(blue) REEP5 monomers and dimers. d Co-immunoprecipitation assays in HEK293 cells. REEP5-V5 and CnVA-REEP5 were transfected into cells and
precipitated with V5 or ﬂag antibody. Left, control immunoblot experiments. Right panel, CnVA-REEP5 was immunoprecipitated via anti-V5 antibody in
REEP5-V5-6xHis transfected HEK293 cells. e Immunoblot analysis of C2C12 cells transfected with REEP5 truncation mutants shows depletion of REEP5
dimers in the absence of the carboxyl terminal domain. f Confocal imaging analysis of EYFP (green) and DAPI (blue) staining shows truncation of the
carboxyl terminal domain of REEP5 (Δ114–189) causes ER luminal vacuolization in transfected C2C12 myoblasts. Scale, 10 μm. Right, image intensity
analysis along axis. g Schematic diagram of truncated REEP5 mutant constructs fused with GFP. Amino acid sequences are shown. h Live-cell confocal
imaging of C2C12 myoblasts expressing the carboxyl-terminus truncated mutant of REEP5 (Δ114–189) and recombinant mCherry-fused mitochondrial
targeting signal (mCherry-mito) or luminal ER marker (mCherry-KDEL). Scale, 10 μm. i Live-cell confocal imaging of C2C12 myoblasts expressing four
truncated REEP5 mutants co-expressed with mCherry-KDEL suggests the importance of the C-terminal cytosolic domain of REEP5 in stabilizing ER
membrane curvatures. Scale, 10 μm. Source data containing original uncropped immunoblots are provided as a Source Data ﬁle. All images shown are
representative of approximately 40–50 total images captured per condition, n= 3 independent biological replicates.
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CKAP4. A ﬁne balance between SR/ER structure proteins has
been proposed to be critical for generating and maintaining a
dynamic SR/ER network as overexpression of membrane curva-
ture stabilizing proteins generates long, unbranched tubules with
a marked decrease in tubular three-way junctions and absence of
membrane fusion were observed with ATL inactivation43–45.
Wang et al.46 further demonstrated the roles and cooperation
between ATLs and RTNs in ER three-way junction morphology
and maintenance in Xenopus laevis eggs. Our results support the
interactions of these SR/ER structure proteins in primary cardiac
myocytes. Moreover, we show that disruption of these interac-
tions through REEP5 depletion resulted in a marked increase in
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the expression levels of RTN4, ATL3, and CKAP4 in mouse
ventricular myocardium. Interestingly, a marked increase in the
expression of RTN4 was observed in our germline reep5 CRISPR
mutant whereas a clear reduction in the expression levels of ATL3
and CKAP4 were detected. Altogether, these data suggest that
REEP5 may act upstream of other ER structure proteins or may
possess a more critical role in the heart. While increased RTN4
protein expression may be sufﬁcient to compensate for the loss of
REEP5 in CRISPR-based reep5 null zebraﬁsh embryos, this does
not appear to be the case in our in vivo studies in the mouse with
the rapid knockdown of REEP5 via viral deletion. Furthermore,
REEP5 interaction with a previously unassociated sheet-ER sta-
bilizing protein, CKAP4, may explain the importance of REEP5
in stabilizing membrane curvature at the edges of ER sheets47.
This interaction may be important for cardiac SR structure as
primary cardiac myocytes are more complex than yeast or X.
laevis.
Mutations and altered protein modiﬁcations in many
ER morphology proteins including ATL1, REEP1, and
REEP2 account for the most common forms of a human neu-
rodegenerative disorder known as the hereditary spastic
paraplegias30,48,49. In addition, recent studies demonstrate that
genetic mutations in REEP6 are responsible for causing retinitis
pigmentosa19,20, an inherited retinal dystrophy characterized by
loss of photoreceptors in the retina. REEP5 protein levels in the
context of cardiac disease showed increased REEP5 expression in
mouse hypertrophic cardiomyopathy and human idiopathic heart
disease, indicating a potential role of REEP5 in the progression
and development of heart disease. These results suggest that
proper REEP5 protein expression contributes to SR/ER integrity
and maintenance in cardiac myocytes and may be responsible for
altered SR/ER functions and morphological defects in cardiac
disease. In fact, in vitro REEP5 depletion in isolated cardiac
myocytes resulted in activation of ER stress and the initiation of
ER-dependent cell death as seen by caspase-12 activation.
We observed phenotypic discrepancies between our morphant,
crispant, and germline CRISPR reep5 mutant models in zebraﬁsh
that we believe can be attributed to the fundamental difference
between knockdown and knockout experimental approaches.
Morpholino and crispant-driven knockdown experiments in
zebraﬁsh embryos allow investigations of acute embryonic
phenotypes in embryos whereas the generation of genetically
mutated homozygous mutants provides a window for physiolo-
gical adaptation or genetic compensation. Previously, activation
of genetic compensation only in response to deleterious
mutations, but not in knockdown-driven morphants or crispants,
has been observed in zebraﬁsh42. Similar compensatory phe-
nomena, as well as differences between knockdown and knockout
models, have also been reported in yeast50. In fact, a signiﬁcant
upregulation of RTN4 in the reep5 germline mutant but not in
REEP5 morphants suggests that the consequence of germline
reep5 deletion is perhaps masked by the upregulation of RTN4 in
the germline reep5 mutant hearts.
Nevertheless, our REEP5 crispant data in the zebraﬁsh
embryos are consistent with in vitro REEP5 depletion experi-
ments in the myocyte and in vivo depletion in the mouse. In both
cases, altered cell morphology and abnormal heart morphology
were observed, highlighting the fundamental role of REEP5 in
cardiac biology. Of course, abnormal ﬁsh phenotype must always
be approached in a very critical manner51. However, given that
we observed consistent phenotypes within the myocytes in vitro,
and zebraﬁsh and mouse hearts in vivo, it is highly probable that
the observed phenotypes are a direct result of REEP5 deﬁciency.
Our results are supported by a recent study that generated
CRISPR/Cas9-mediated inactivation of REEP5 in rat ventricular
myocardium with a preliminary characterization that showed
depressed cardiac contractility in pressure–volume loops52.
Interestingly, inactivation of REEP5 in rats displayed a weaker
and nonlethal cardiac phenotype compared to our REEP5-
depleted mouse model. This discrepancy in phenotype severity
may be a species-dependent difference, or a result of differences
in knockdown vs. knockout approaches similar what we observed
in our zebraﬁsh studies.
Taken together, our results suggest an indispensable role of
REEP5 in the SR/ER to maintain a highly differentiated SR net-
work in cardiac muscle cells. In conclusion, we believe a more
complete understanding of the role of REEP5 in the heart will be
critical to understand the normal function of healthy versus
diseased SR/ER.
Methods
Human myocardium. All procedures involving human samples were approved by
the University Health Network Ethics Review Committee (REB reference #158781-
AE, 136800-AE, and 10-0703) and were performed in accordance with the
guidelines. Written informed consent was obtained from all patients for use of their
samples in research prior to study commencement. Human idiopathic tissue was
isolated from a 58-year-old female and the ischemic cardiomyopathy tissue was
isolated from a 68-year-old male during implantation of a left ventricular assist
device at the Peter Munk Cardiac Centre (Toronto, Ontario). Healthy human left
ventricle lysates were obtained from BioChain (Cat#: P1234138).
Mouse heart disease tissues. In all, 4 and 8 week TAC cardiac tissue were
collected as described53. Two-week post LAD induced MI hearts were induced and
isolated as described previously54. Finally, 16-week-old PLN R9C mutant mice, a
model of human DCM were analyzed as described55.
Adult and neonatal mouse cardiac myocyte isolation. All experimental proce-
dures were conducted in accordance with the Animal Care Guidelines approved by
University of Toronto Animal Use and Care Committee. Protocol for isolation of
adult mouse cardiac myocytes was modiﬁed from Ackers-Johnson et al.56. Brieﬂy,
Fig. 6 Mass spectrometry analysis identiﬁes REEP5 interactions with known cardiac SR shaping proteins. a Immunoblot analysis of nickel-His
puriﬁcation of CnVA-REEP5 from transfected HEK293 cells shows stable expression of CnVA-REEP5 and successful immunoprecipitation of CnVA-REEP5
monomer (~34 kDa) and dimer (~68 kDa). b Identiﬁcation of known SR/ER-shaping proteins as REEP5 interacting proteins by mass spectrometry analysis.
Average precursor MS1 peak areas (peptide m/z signal) as deﬁned by iBAQ (intensity based absolute quantiﬁcation) are shown, n= 3 independent mass
spectrometry runs. To calculate fold change, average null values (n.d.—not detected) were inputted with a value of 10. RTN reticulon, ATL atlastin, CKAP4
cytoskeleton-associated protein 4, ACTC1 alpha cardiac muscle actin 1, MYL6 myosin light chain 6, GAPDH glyceraldehyde-3-phosphate dehydrogenase.
Asterisks indicate a statistically signiﬁcant p value in a Tukey’s multiple comparison analysis where *p < 0.05. c RNASeq analysis of the RTN, ATL families
of proteins, and CKAP4 in human fetal heart and adult heart tissue data using data from Human Protein Atlas. d Immunoblot analysis of nickel-His REEP5
immunoprecipitation lysates for RTN4/Nogo-A/B, ATL3, and CKAP4, n= 3. e HEK293 cells were transfected with myc-tagged Nogo-A and Nogo-B
plasmids and detected with myc and α-tubulin antibodies. f Co-immunoprecipitation assay of cotransfected HEK293 cells with anti-REEP5 antibody (left
panel) and anti-RTN4/Nogo-A/B antibody (right panel) demonstrated interaction between REEP5 and RTN4, n= 3. Eluates were collected on ice and
loaded directly for blotting, or samples were boiled prior to blotting. g–j Co-immunoprecipitation and reverse order co-immunoprecipitation assays with
g anti-REEP5, h anti-RTN4/Nogo-A/B, i anti-ATL3, and j anti-CKAP4 antibodies in adult mouse cardiac microsomes (input), followed by immunoblots
analysis, n= 5. Source data containing original uncropped immunoblots are provided as a Source Data ﬁle.
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Fig. 7 In vivo CRISPR/Cas9-mediated REEP5 depletion in zebraﬁsh embryos leads to cardiac abnormalities. a Immunoﬂuorescence analysis of REEP5
expression in wild-type zebraﬁsh hearts at 48 and 96 hpf. Co-staining for REEP5 (green), zn-8 (general plasma membrane; red) and DAPI (nuclear; blue)
revealed REEP5 expression in both ventricular and atrial cardiac myocytes, with no nuclear or membrane localization evident. Scale, 50 μm. b–e CRISPR/
Cas9-mediated depletion of REEP5 with varying gRNA concentrations reveals the contribution of REEP5 to embryonic heart development in zebraﬁsh
embryos. Images shown are representative of 331 control, 410 2× REEP5 gRNA, and 296 3× REEP5 gRNA total injected embryos, n= 3 independent
biological replicates. Scale, 500 μm. f, g Optical imaging analysis of control and 2× REEP5 gRNA injected embryos shows cardiac looping defects associated
with REEP5-targeted gRNA injection. Scale, 10 μm. h Movie analysis of REEP5 gRNA injected embryos shows dyssynchronous atrio-ventricular beating
rhythms compared to control zebraﬁsh embryos. Area proﬁles were smoothened with a Gaussian curve with σ= 0.2 s. i–k Bar graphs showing i phenotypic
penetrance represented as percentage, j heart rate represented as beats per minute (bmp), and k atrioventricular beating dyssynchrony represented as
percentage from 331 control, 410 2× REEP5 gRNA, and 296 3× REEP5 gRNA total injected embryos, n= 3 independent biological replicates. Asterisks
indicate a statistically signiﬁcant p value in a Tukey’s multiple comparison analysis where *p < 0.05, **p < 0.01, and ***p < 0.001; data are presented as
mean ± SEM.
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6–8-week-old male CD1 (Jackson Labs) mouse hearts were perfusion-isolated using
10 mL of EDTA buffer, followed by digestion with warmed collagenase II buffer
(525 units/mL; LS004176, Worthington Biochemical Corp., Lakewood, NJ, USA).
Following dissociation and washing, myocytes were resuspended in culture media
and plated on laminin coated glass-bottom dishes. Primary mouse neonatal cardiac
myocytes were isolated from CD1 mice as previously described57. Pups (p1–3) were
decapitated and hearts were washed in ice-cold Hanks-balanced salt solution
without calcium and magnesium. Atria were discarded and ventricles were dis-
sected into 2-mm fragments, and enzymatically digested in 0.05% trypsin (Hank’s
balanced salt solution) on an end-to-end rotor overnight at 4 °C. Next day, cells
were released with 450 unit/mL collagenase II (LS004176, Worthington Biochem-
ical Corp., Lakewood, NJ) at 37 °C (15 min/digestion) until no tissue remaining.
Collected cells were ﬁltered through a 70-µm cell strainer (08-771-2, Fisher
Scientiﬁc), span down at 200g for 5 min at room temperature and pre-plated at
37 ° C for 2 h in DMEM/F12 medium supplemented with 10% fetal bovine serum
(FBS)/horse serum. Cells were then seeded on gelatin-coated glass-bottom dishes
for 48 h before being maintained in culture medium (insulin-transferrin-sodium
selenite media supplement, 10 µM BrdU, 20 µM cytosine β-d-arabinofuranoside,
2.5 µg/mL sodium ascorbate, 1 nM LiCl, 1 nM thyroxine).
Cell culture. Human embryonic kidney (HEK-293T) cells and murine C2C12
myoblasts were maintained in DMEM supplemented with 10% FBS, penicillin and
streptomycin. For transgene expression, HEK-293T cells were transfected using
polyethylenimine (Polysciences, Inc., Warrington, PA) and C2C12 myoblasts were
transfected with Lipofectamine 2000 (Invitrogen) as described57.
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Membrane yeast two-hybrid experiments. The MYTH system58 was used to
validate REEP5 membrane topology as previously described27. Brieﬂy, N-terminal
TF transcription factor tagged TF-Cub:REEP5 “bait” REEP5 protein and ubiquitin
fragments tagged (NubI and NubG) “prey” proteins were tested for protein–protein
interactions. Upon reconstitution of TF-Cub and NubI tagged membrane proteins,
TF is released to enable reporter activation. A mutant form of the ubiquitin
fragment (NubG) that contains a I13G mutation only allows reconstitution with
Cub when brought in close proximity by physically interacting proteins. If the bait
REEP5 protein is targeted to the membrane, the N-terminal tagged bait will expose
its Cub fragment in the cytosol to interact with interact with NubI, but not with
NubG. Both Cub and Nub tagged proteins must be exposed in the cytosol for
reconstitution and subsequent reporter activation. Activation of the reporter sys-
tem was measured as growth on media.
Lentiviral transduction of isolated mouse cardiac myocytes. Lentivirus-
mediated transduction for shRNA delivery in mouse neonatal and adult cardiac
myocytes was conducted as previously described57. Brieﬂy, lentivectors were cre-
ated by triple transfections of pLKO.1-mREEP5 (trcn0000106187, RNAi con-
sortium), pSPAX2, and pMD2.G in HEK-293T cells. A lentivector carrying
scrambled shRNA was used as control. For transduction of cardiac myocytes,
mouse neonatal and adult cardiac myocytes were incubated with 8 µg/mL poly-
brene for 90 min and incubated with lentiviral solution for 21 h at 37 °C, 5% CO2.
Transduced cells were cultured in fresh media for at least an additional 24 h prior
to any experiments.
Adeno-associated viral transduction in vivo in mice. All adeno-associated viral
(AAV9) parent vectors were obtained from Dr. Roger Hajjar (Mount Sinai School
of Medicine, New York) and high titer AAV9 vectors were generated via a triple
transfection approach in HEK293 cells as previously described59,60. Brieﬂy,
HEK293 cells were transfected with 15 µg of pDG9 plasmid and 5 µg desired AAV
plasmid per plate. HEK293 cells were harvested 48 h post transfection for sub-
sequent puriﬁcation by ﬁltration and iodixanol. For in vivo transduction, neonatal
(P10) pups from wild-type CD1 mice (Jackson Labs) were injected intraperitonially
5 × 1011 genomic titer of AAV9 virus carrying either mouse REEP5 shRNA or
scrambled shRNA sequence (non-expressing control) and were monitored daily.
Echocardiographic assessment of cardiac function in mice. All mice were
anesthetized with 1.5% isoﬂurane and placed on an animal warming pad main-
tained at 37 °C throughout the procedure. Heart rate, respiration, and body tem-
perature were monitored and maintained consistently throughout the ultrasound
imaging session. All mice were imaged in the supine position using Vevo 3100
Imaging system (Visual Sonics Inc., Toronto) with a 30MHz probe. Standard 2D
echocardiographic assessment (B-Mode and M-Mode) was performed through the
left para-sternal acoustical window to assess left ventricular dimensions and heart
function61,62. M-mode recording from the middle segment of the left ventricle was
made to measure the left ventricular anterior and posterior wall thickness at peak
systole and end diastole. Pulsed Wave Doppler Mode was used to acquire doppler
ﬂow proﬁles and to record velocity time integrals. Subsequent measurements and
analyses were performed using the Vevo 3100 2D quantiﬁcation software to cal-
culate interventricular septal thicknesses, posterior wall thickness, systolic dimen-
sion, ejection fraction, and cardiac output.
Immunoblotting and IF. Protein lysates from cells and tissues were harvested in
radioimmunoprecipitation assay buffer (RIPA, 50 mM Tris-HCl; pH 7.4, 1% NP-
40, 0.5% sodium deoxychloate, 0.1% SDS, 150 mM NaCl, 2 mM EDTA), supple-
mented with protease and phosphatase inhibitors (Roche), for 30 min on ice, spun
down at 15,000g/4 °C. Soluble fractions were saved for immunoblotting. For live
imaging, cells were seeded on glass-bottom dishes (MatTek Corp. Ashland, MA),
and transfected with plasmids for ﬂuorescence protein expression. Cells were
directly visualized 24 and 48 h following transfection. For IF, cells were ﬁxed with
4% paraformaldehyde for 10 min on ice, permeabilized with ice cold 90% methanol
at −20 °C for 10 min, and blocked with blocking solution (3% FBS and 0.1%
TritonX-100 in PBS) at room temperature for 1 h. Primary antibody staining was
carried out overnight at 4 °C and ﬂuorophore-conjugated secondary antibody
staining was performed at room temperature for 1 h in the dark. Samples were
visualized with Zeiss spinning disk confocal microscopy (Zeiss Spinning Disk
Confocal Microscope). Three-dimensional reconstruction of z-stack images was
carried out using Imaris 8.1 software (Bitplane, Switzerland).
Transmission electron microscopy. Isolated adult mouse cardiac myocytes were
ﬁxed in 2.5% glutaraldehyde in 0.1 M phosphate buffer, while zebraﬁsh were ﬁxed
in 2% paraformaldehyde in 0.1 M sodium cacodylate at 4 °C overnight. Samples
were postﬁxed in 1% osmium tetroxide buffer and processed through graded
alcohols and embedded in Quetol-Spurr resin. Sections of 90–100 nm were cut and
stained with uranyl acetate and lead citrate and imaged at ×20,000 magniﬁcation
using a Hitachi TEM microscope at the Department of Pathology, St. Michael’s
Hospital (Toronto, Canada) or a FEI Tecnai 20 TEM microscope at the Hospital
for Sick Children (Toronto, Canada)35.
Antibodies. Primary rabbit polyclonal anti-REEP5 antibody (IB: 1:1000 dilution,
IF: 1:800 dilution; 14643-1-AP; Proteintech), polyclonal anti-Nogo-A/B (IB: 1:1000
dilution, IF: 1:1000 dilution; PA1-41220; ThermoFisher), polyclonal anti-ATL3
antibody (IB: 1:1000 dilution, IF: 1:800 dilution; PA5-24652; ThermoFisher),
polyclonal anti-CKAP4 antibody (IB: 1:1000 dilution, IF: 1:800 dilution; PA5-
42926; ThermoFisher) and mouse monoclonal anti-Alpha sarcomeric actinin
antibody (IF: 1:500 dilution; MA1-22863; ThermoFisher), monoclonal anti-Triadin
antibody (IF: 1:500 dilution; MA3-927; ThermoFisher), monoclonal anti-RyR2
antibody (IF: 1:500 dilution; ab2827; Abcam) were used for immunocytochemistry
and immunoblot studies. Anti-alpha tubulin (#2144), anti-GRp78 (#3177), anti-
GRp94 (#2104), anti-GAPDH (#2118) antibodies from Cell Signaling; anti-ATF4
(ab216839), anti-Caspase12 (ab62484) antibodies from Abcam were used for
immunoblot studies at 1:1000 dilution. Anti-GFP (sc390394) antibody from Santa
Cruz Biotechnology was used for immunoblot studies at 1:1000 dilution.
ROS and MMP measurements. Intracellular ROS was measured using CellROX
Deep Red reagent (Invitrogen) according to the manufacturer’s instructions.
Neonatal cardiac myocytes were cultured and seeded in 96-well plates or glass-
bottom dishes. Cells were incubated with the ROS scavenger, Tiron (1 mM, Sigma)
for 30 min at 37 °C, 5% CO2 followed by a 30 min incubation with CellROX
reagent at a ﬁnal concentration of 5 μM. MMP was detected in cells using 50 nmol/
L of vital mitochondrial dye JC-1 (Molecular Probes). Cells were washed with
culture medium before and after a 20 min incubation period with JC-1 at 37 °C, 5%
CO2; ﬂuorescence was then measured via plate-reader analysis35.
MTT viability assay. Cell viability was assessed by performing 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma-Aldrich)
according to the manufacturer’s instructions61. Neonatal cardiac myocytes were
seeded in 96-well plates. Cells were incubated in absence of light with 0.5 mg/ml
MTT at 37 °C, 5% CO2 for 1 h. Untransformed MTT was removed and formazan
crystals were solubilized with dimethyl sulfoxide (DMSO) followed by ﬂuorescence
measurement at 570 nm using Perkin Elmer plate reader.
Fig. 8 Genetic compensation in reep5 CRISPR knockout zebraﬁsh mutant. a Sequencing analysis generated by Sanger Synthego shows reep5 gRNA
targeted and edited homozygous CRISPR mutant sequences in the region around the guide sequence. The horizontal black underlined region represents the
guide sequence and the horizontal red underline indicates the protospacer adjacent motif (PAM) site with the vertical black line representing the cut site.
b, c CRISPR/Cas9-mediated reep5 homozygous mutant compared to control zebraﬁsh embryos, n= 3 independent biological crosses. Scale, 500 μm.
d, e Optical imaging analysis of control and reep5 CRISPR mutant embryos shows normal cardiac chamber orientation and development in the reep5 CRISPR
mutant hearts. Scale, 10 μm. f Heart rate analysis of control and reep5 homozygous mutant embryos upon 600 μM verapamil treatment for 30min; a total
of 46 control, 24 reep5 CRISPR mutants, 32 control+ verapamil, and 36 reep5 CRISPR mutants+ verapamil embryos were analyzed, n= 3 independent
biological crosses; data are presented as mean ± SEM. g, h reep5 CRISPR mutants injected with REEP5 MO (1 ng) appears phenotypically normal compared
to overt cardiac abnormalities in the REEP5 morphant embryos. Images shown are representative of 287 REEP5 MO and 232 reep5 CRISPR mutants
injected with REEP5 MO embryos, n= 3 independent biological crosses. Scale, 500 μm. i, j Optical imaging analysis of REEP5 MO and reep5 CRISPR
mutants injected with REEP5 MO embryo hearts shows normal cardiac chamber orientation and development in the reep5 CRISPR mutant hearts. Scale,
10 μm. k Bar graph showing phenotypic penetrance represented as percentage from 287 REEP5 MO and 232 reep5 CRISPR mutants injected with REEP5
MO embryos, n= 3 independent biological crosses; data are presented as mean ± SEM. l Immunoblot analysis of cardiac-enriched ER structure proteins
(RTN4, ATL3, and CKAP4) in reep5 CRISPR homozygous mutants shows upregulation of RTN4 in reep5 CRISPR mutant hearts. Source data containing
original uncropped immunoblots are provided as a Source Data ﬁle. Asterisks indicate a statistically signiﬁcant p value in a Tukey’s multiple comparison
analysis where **p < 0.01 and ***p < 0.001.
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Fig. 9 In vivo AAV9-mediated REEP5 depletion in mice results in increased cardiac ﬁbrosis, activated cardiac ER stress, cardiac dysfunction, and
death. a Immunoblot analysis of AAV9-mediated REEP5 depletion in mice 4 weeks post viral infection. b Histological analyses of AAV9 Scram shRNA and
REEP5 shRNA injected mouse hearts at 4 weeks post viral infection. Top panels: H&E, bottom panels: Masson’s trichrome stain. Scale, 20 μm. All images
shown are representative of approximately 20 total images captured per condition, n= 3 independent biological replicates. c Transmission electron
microscopy analysis of AAV9 REEP5 shRNA-injected myocardium reveals degeneration of muscle ﬁbers and disrupted SR membranes and organization
compared to scram controls. M mitochondria, SR sarcoplasmic reticulum, V vacuoles. Scale, 0.5 nm. All images shown are representative of approximately
20 total images captured per condition, n= 3 independent biological replicates. d In vivo echocardiographic heart function assessment of AAV9 scram and
AAV9 REEP5 shRNA-injected mice at 4 weeks post viral infection, n= 5. e Echocardiographic M-mode and B-mode measurements showed signiﬁcantly
compromised cardiac function with reduced cardiac ejection fraction and cardiac output, n= 5 independent biological replicates. Asterisks indicate a
statistically signiﬁcant p value in a Tukey’s multiple comparison analysis where ***p < 0.001; data are presented as mean ± SEM. f Immunoblotting analysis
of cardiac ER stress markers (GRp78, GRp94, XBP1, ATF4, and CHOP) and ER-dependent apoptosis (caspase 12) upon AAV9-induced REEP5 depletion
in vivo in mice, n= 3; p values are shown. g Immunoblots of RTN4, ATL3, and CKAP4 upon AAV9-induced REEP5 depletion in vivo in mice, n= 3
independent biological replicates. Source data containing original uncropped immunoblots are provided as a Source Data ﬁle.
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Protein puriﬁcation and mass spectrometry analysis. Eluted REEP5 pulldown
lysates were concentrated using a 3000 MWCO centrifugal concentrator (Milli-
pore), reduced with 5 mM DTT for 30 min at 55 °C, alkylated with 25 mM
iodoacetemide for 30 min at room temperature in the dark. Proteins were trypsi-
nized using 5 µg Trypsin Gold (Promega) overnight at 37 °C and halted via acid-
iﬁcation with formic acid to a concentration of 1%. Peptides were then passed
through using OMIX C18 Tips (Agilent) and quantiﬁed via BCA assay (Ther-
moFisher). For REEP5-transfected lysates and untransfected controls, three bio-
logical replicates were analyzed on a Q Exactive Plus mass spectrometer
(ThermoFisher). Brieﬂy, 2 µg of peptides were separated on a 2-h 5–35% acet-
onitrile gradient on a 10 cm long, 75 µm i.d analytical column packed with 3 µm
100 Å C18 resin (Phenomenex). Data were acquired at R= 70,000 at 400 m/z with
one full MS1 scan from 400 to 1500 m/z followed by 12 data-dependent MS2 scans
at R= 17,500 with dynamic exclusion set to 60 s. Two biological replicates for each
condition was run in technical duplicates. RAW ﬁles were searched using Max-
Quant version 1.5.4.163 using the UniProt human proteome sequence database.
Variable modiﬁcations were set for methionine oxidation and protein amino
terminal acetylation. False-discovery rate was set to 1% using a target-decoy
strategy. Proteins identiﬁed in only 2 of 8 MS experiments were excluded for
comparison. Expression levels were used using iBAQ values determined by
MaxQuant.
In vivo studies in zebraﬁsh. Adult zebraﬁsh were maintained according to
Canadian Council on Animal Care (CCAC) and The Hospital for Sick Children
Animal Service (LAS) guidelines. Transgenic zebraﬁsh line used in this study was
myl7:EGFPtwu34,64. Zebraﬁsh embryos were grown at 28.5 °C in embryo medium as
previously described65. Standard techniques were used for microinjection66.
Microinjection was repeated a minimum of ﬁve times with consistent results.
Morpholino oligos were purchased from Genetools (Oregon, USA). The ATG
REEP5 morpholino (5′-GCC GCC ATG ATT TGT CTG AAG GGA T-3′) and
ATG REEP6 morpholino (5′-AGT CAC CAT GTT TGC CAT ATT TAC A-3′)
were injected at a concentration of 1 ng/nl at the 1-cell stage of development.
Bright-ﬁeld images were taken using a Zeiss AXIO Zoom V16. Whole-mount
immunoﬂuorescence (IF) was carried out as previously described67. Secondary
reagents AF488 goat-anti-mouse IgG1 recognizes monoclonal antibody S46 (atrial
myosin heavy chain), AF555 goat anti-mouse IgG2b recognizes monoclonal anti-
body MF20 (Myosin heavy chain), AF488 goat anti-rabbit IgG recognizes antibody
REEP5 and goat anti-mouse IgG 568 recognizes monoclonal neuronal cell surface
marker (zn-8). MF20, S46 and ZN-8 primary antibodies were obtained from the
Developmental Studies Hybridoma Bank (University of Iowa, IA, USA). Immu-
noblotting for REEP5 detection was carried as described above using 40 embryos
per experimental condition. IF confocal images were taken with a Nikon A1R laser
scanning confocal microscope or using Zeiss spinning disk confocal microscopy
(Zeiss LSM 510/AxioImager.M1 Confocal Microscope). For in vivo RNA rescue
experiments, Full-length wild-type zebraﬁsh reep5 coding sequence was ampliﬁed
from 48 hpf wild-type zebraﬁsh cDNA. The coding sequence was modiﬁed to avoid
interaction with the antisense morpholino while producing the same amino acids
(5′ATGGCAGCAGCGTTA…TAA-3′). This modiﬁed coding sequence was sub-
cloned into the pCS2+ vector. For mRNA production, the pCS2+ :reep5 construct
was linearized via NotI digestion and in vitro transcription was carried out using
the mMessage mMachine SP6 kit (Ambion). To validate the morphant phenotype,
RNA rescue was performed via subsequent injection of antisense reep5 morpholino
and reep5 mRNA. 1 ng/µL (1 nL volume) of reep5 morpholino was injected at the
one-cell stage, immediately followed 100 pg (1 nL volume) of reep5 mRNA.
Embryos were incubated at 28.5 °C and monitored daily.
CRISPR/Cas9 reep5 mutants were generated as previously described68. To
generate reep5 CRISPR mutants, exon sequences were analyzed for optimal
cut sites using the Benchling web-based service (www.benchling.com). gRNA target
sequences were ranked by highest off-target score followed by highest on-target
score which resulted in a gRNA cut site in exon 3 targeting the beginning of
the second transmembrane domain (5′-AAAATGGCTGACCTACTGGG). The
REEP5-speciﬁc oligo using the T7 promoter with the standard overlap region was
ordered from ThermoFisher (5′-TTAATACGACTCACTATAGG-AAAATGG
CTGACCTACTGGG-GTTTTAGAGCTAGA). Once the template oligo was
assembled, transcription was performed using the T7 Quick High-Yield RNA
Synthesis Kit (NEB). The resulting RNA was puriﬁed using the standard ethanol/
ammonium acetate protocol69. An injection mix was prepared with gRNA and
Cas9 protein in a 1:1 ratio at a concentration of 2 mM (1×). 1–3 nL of the solution
was injected into zebraﬁsh embryos at the 1-cell stage of development to achieve
1×, 2×, or 3× amounts of gRNA. Standard microinjection techniques were used69.
CRISPR/Cas9 gRNA cutting was evaluated in injected and uninjected 4 dpf
embryos using a LightCycler 96 from Roche. Analysis was conducted using the
Roche template for the HRM assay. Injections and HRM analysis were repeated 3
times with consistent results. Germline CRISPR reep5 homozygous MZ mutants
were generated by performing an additional cross with an identiﬁed homozygous
female reep5 mutant to rule out maternally-contributed mRNA expression of
REEP5. The effects of verapamil were tested in 2 dpf wild-type and reep5
homozygous mutant ﬁsh. Concentrations of 10, 5, 2.5, 1.25, and 0.6 mg/mL of
verapamil in 1 mL of E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2,
0.33 mM MgSO4) were tested, with 0.6 mg/mL having no measurable effect on
wild-type embryo heartbeat. Embryos were examined for phenotypes following
30 min of drug exposure using a Zeiss standard dissection microscope. Heart rate
was recorded before and after drug treatment with atrial and ventricular heartbeats
counted separately over a period of 15 s each.
Plasmids and reagents. Human REEP5 (NM_005669.4) was subcloned into pLD-
puro-CnVA38 and pcDNA-DEST40 (V5/6×-His epitope) plasmids by Gateway
cloning technology according to manufacturer’s manual (Invitrogen). Truncation
deletions were generated using available restriction digest sites. For the truncation
deletion removing the cytosolic C-terminus region, only sequences around amino
acid 114 were viable restriction sites, resulting in the 1–114 and Δ114–189 con-
structs; attempts at generating different C-terminal mutants were not successful.
pmCherry-Sec61β was created as previously descripted70. Brieﬂy, mouse Sec61β
(NM_024171) was PCR ampliﬁed with primers 5′-CAT CAT AGA TCT ATG
CCG GGT CCA ACG CCC-3′ (mSec61 SP, BglII) and 5′-GTA GTA GAA TTC
CTA TGA TGA TCG CGT GTA CTT GCC CCA-3′ (mSec61 AP, EcoRI) and
subcloned in a pmCherry-C1 plasmid with the same restriction sites. The PCR was
performed with following parameters: 1 cycle of 98 °C for 30 s, 35 cycles of 98 °C
for 10 s and 72 °C for 10 s, and 1 cycle of 72 °C for 2 min. All constructs were
validated by sequencing at the ACGT Corp (Toronto, ON, Canada).
Movie analysis. Zebraﬁsh bright-ﬁeld movies were captured using a Zeiss AXIO
Zoom_V16 at ×63 magniﬁcation. Embryos injected with or without REEP5 MO
were subjected to PTU for removal of pigmentation prior to movie capture. To
measure atrial and ventricular area, we performed imaging analysis using SIESTA,
a custom-built image analysis package71,72. Speciﬁcally, we applied the LiveWire
algorithm implemented in SIESTA for semi-automated delineation of heart
chambers. Area proﬁles were smoothened with a Gaussian curve where σ= 0.1 s
and normalized by dividing by the mean area in each proﬁle.
Adult mouse cardiac myocytes time-lapse images were obtained using a
Revolution XD spinning disk confocal microscope equipped with an iXon Ultra
897 camera (Andor, Belfast, UK) and a ×1.5 coupling lens. A ×40 oil immersion
lens (Olympus, NA 1.35) was used to acquire one 16-bit image every 40 ms. Image
analysis was performed using algorithms developed with Matlab (MathWorks,
Natick, MA) and DIPImage (Delft University of Technology, Delft, Netherlands).
To measure cardiac myocyte area over time, we binarized images of isolated cardiac
myocytes using the image mean as the threshold. A Savitzky-Golay ﬁlter with
second order polynomials and a window size of 75 pixels was used to smooth the
cardiac myocyte outlines prior to quantiﬁcation. To measure fractional shortening,
we calculated the equation of the line along the longest axis of each cardiac
myocyte and measured the length of the cell under the line over time. We
normalized length data to the ﬁrst time point at which the cell is at rest between
contractions, and detrended the signal by subtracting the best-ﬁt sixth order
polynomial. We considered a contraction event to correspond to fractional
shortening of 5% or more of the initial rest length and the ﬁndpeaks function in
Matlab was used to identify contractile pulses and averaged their amplitude for
each cell. Frequency was calculated as the inverse of the mean period between
contractile events.
Statistical analyses and reproducibility. Experimental measurements were ana-
lyzed and graphically presented by the GraphPad Prism8 software. Descriptive
statistics are shown as mean ± SEM. Data are plotted as mean ± SEM with indi-
vidual data points as scatter plot overlays. Normally distributed data were analyzed
using two-way ANOVA followed by post hoc Tukey’s multiple comparison test for
each mean comparison. Experimental mean-fold protein intensities, relative to
controls from triplicate assays, were considered different from controls at the p <
0.05 signiﬁcance level. All immunoblots shown are representative immunoblots
from a minimum of three independent biological replicates. Source data containing
the raw data underlying all reported averages in graphs and charts and all original
uncropped immunoblots are provided as a Source Data ﬁle.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that all supporting data are available within the article and
supplementary ﬁles, or from the corresponding author upon reasonable request.
Publically available RNASeq and proteomic data were downloaded and analyzed.
Speciﬁcally, the following mRNA Affymetrix transcript data from GEO proﬁles in NCBI
for mouse cardiac tissue and disease were obtained: severe DCM (GDS487/96115_at), 2d,
10d, 21d TAC (GDS794/103886_at), MI (GDS3655/14195), alpha-tropomyosin mild
HCM (GDS2134/1419398_a_at), and Emery-Dreifuss (GDS2884/1426376_at). Similarly,
we obtained human mRNA Affymetrix GEO proﬁles for human heart transplant
rejection (GDS2386/208872_s_at), human inﬂammatory DCM (GDS2154/208873_s_at),
DCM (GDS4772/8113542) as well as human idiopathic and ischemic CM (GDS651/
208872_s_at). Data were reported as normalized hybridization signals. Comprehensive
human RNASeq based transcript levels were obtained from the Human Protein Atlas
Project73. For that normal human tissue, RNA samples were extracted from frozen tissue
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sections in the Uppsala Biobank. Data were reported as the abundance in “Transcript Per
Million” (TPM) as the sum of the TPM values of all its protein-coding transcripts73.
The source data underlying Figs. 1e, h, 3b–e, g, 4d, e, 6c, 7i–k, 8f, k, 9e, and
Supplementary Fig. 3a are provided as a Source Data ﬁle.
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